Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9815837 Polymorphs

Patent 9815837 was granted and assigned to Boehringer Ingelheim on November, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Boehringer Ingelheim

0

Current Assignee

Boehringer Ingelheim

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Dirk Kemmer0

Martin Renz0

Peter Kohlbauer0

Peter Sieger0

Thomas Nicola0

Date of Patent

November 14, 2017

0

Patent Application Number

152858710

Date Filed

October 5, 2016

0

Patent Citations Received

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

0

US Patent 11919903 Polymorphs

0

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

0

Patent Primary Examiner

0

Patent abstract

The invention relates to polymorphous crystal modifications of a DPP-IV inhibitor, the preparation thereof and the use thereof for preparing a medicament.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9815837 Polymorphs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool